Table 1.
Characteristics of individuals who suffered at least 1 adverse event post COVID-19 vaccination
| Frequency (n and %) |
||||
|---|---|---|---|---|
| Pfizer-BioNTech |
Moderna |
Janssen |
Total |
|
| Parameter | (n = 127.13 million doses) | (n = 104.61 million doses) | (n = 8.23 million doses) | (n = 239.97 million doses) |
| Total affected | 28,745 (20.36) | 61,258 (43.38) | 51,205 (36.26) | 141,208 (100) |
| Age at vaccine dose | ||||
| <18 | 77 (0.27) | 94 (0.15) | 142 (0.28) | 313 (0.22) |
| 18-39 | 9,537 (33.18) | 16,880 (27.56) | 13,873 (27.09) | 40,290 (28.53) |
| 40-59 | 9,496 (33.04) | 20,340 (33.20) | 16,300 (31.83) | 46,136 (32.67) |
| 60 and above | 4,767 (16.58) | 22,066 (36.02) | 15,215 (29.71) | 42,048 (29.78) |
| Missing data | 4,868 (16.94) | 1,878 (3.07) | 5,675 (11.08) | 12,421 (8.80) |
| Gender | ||||
| Male | 8,385 (29.17) | 13,290 (21.70) | 12,243 (23.91) | 33,918 (24.02) |
| Female | 18,744 (65.21) | 47,339 (77.28) | 37,652 (73.53) | 103,735 (73.46) |
| Missing data/ unspecified | 1,616 (5.62) | 629 (1.03) | 1,310 (2.56) | 3,555 (2.52) |